European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency

Hormone Research

Volumn 58, Issue 5, 2002, Pages 233-241

  Juul, Anders ^a   Bernasconi, Sergio ^c   Clayton, Peter E ^b   Kiess, Wieland ^c   DeMuinck Keizer Schrama, Sabine ^d  

^a Rigshospitalet   (Denmark)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c Department of Pediatrics ^*

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Audit; Diagnosis; GH deficiency; Monitoring; Treatment

Indexed keywords

GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROID HORMONE;

ADRENAL FUNCTION; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY SURFACE; BODY WEIGHT; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOSE CALCULATION; DRUG WITHDRAWAL; EUROPE; EVALUATION; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROVOCATION TEST; QUESTIONNAIRE; RADIOGRAPHY; SHORT STATURE; THYROID HORMONE BLOOD LEVEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BODY HEIGHT; BRAIN DISEASES, METABOLIC; CHILD; CHILD, PRESCHOOL; CLINICAL CHEMISTRY TESTS; EUROPE; FEMALE; GROWTH DISORDERS; HEALTH SURVEYS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MEDICAL AUDIT; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PUBERTY, DELAYED; QUESTIONNAIRES;

EID: 0036974908     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066265     Document Type: Article

References (15)

1. Juul A, Bernasconi S, Chatelain P, Hindmarsh P, Hochberg Z, Hokken-Koelega A, de Muinck K, Kiess W, Oberfield S, Parks J, Strasburger GJ, Volta C, Westphal O, Skakkebaek NE: Diagnosis of growth hormone (GH) deficiency and the use of GH in children with growth disorders. Horm Res 1999;51:284-299.
2. Saggese G, Ranke MB, Saenger P, Rosenfeld RG, Tanaka T, Chaussain JL, Savage MO: Diagnosis and treatment of growth hormone deficiency in children and adolescents: Towards a consensus. Horm Res 1998;50:320-340.
3. Guidelines for the Use of Growth Hormone in Children with Short Stature: A report by the Drug and Therapeutics Committee of the Law-son Wilkins Pediatric Endocrine Society. J Pediatr 1995;127:857-867.
4. Carel JC, Tresca JP, Letrait M, Chaussain JL, Lebouc Y, Job JC, Coste J: Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: A population register-based study. J Clin Endocrinol Metab 1997;82: 2117-2121.
5. Price DA: GH testing in KIGS: The clinical reality; in Ranke MB, Wilton P (eds): Growth Hormone Therapy in KIGS - 10 Years' Experience. Heidelberg, Barth, 1999, pp 73-80.
6. Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society. J Clin Endocrinol Metab 2000;85:3990-3993.
7. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F: Reliability of provocative tests to assess growth hormone secretory status: Study in 472 normally growing children. J Clin Endo-crinol Metab 1996;81:3323-3327.
8. Andersson AM, Orskov H, Ranke MB, Shalet S, Skakkebaek NE: Interpretation of growth hormone provocative tests: Comparison of cutoff values in four European laboratories. Eur J Endocrinol 1995;132:340-343.
9. Granada ML, Sanmarti A, Lucas A, Salinas I, Carrascosa A, Foz M, Audi L: Assay-dependent results of immunoassayable spontaneous 24-hour growth hormone secretion in short children. Acta Paediatr Scand Suppl 1990;370:63-71.
10. Wyatt DT, Mark D, Slyper A: Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab 1995;80:3292-3297.
11. Kiess W, Conway G, Ritzen M, Rosenfield R, Bernasconi S, Juul A, van Pareren Y, de Muinck K, Bourguignon JP: Induction of puberty in the hypogonadal girl - practices and attitudes of pediatric endocrinologists in Europe. Horm Res 2002;57:66-71.
12. Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998;83:379-381.
13. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M: Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 1998;279:563-566.
14. Hankinson SE, Willett WC, Colditz GA, et al: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-1396.
15. Juul A: Determination of insulin-like growth factor-I in the monitoring of growth hormone treatment with respect to efficacy of treatment and side effects: Should potential risks of cardiovascular disease and cancer be considered? Horm Res 1999;51(suppl 3):141-148.